CA2463384A1 — Hydrating nasal gel and applicator
Assigned to CNS Inc · Expires 2003-04-17 · 23y expired
What this patent protects
A hydrating nasal gel for shooting nasal tissues within the nasal cavity is described. The gel remains inside the nasal cavity for a substantial period of time to provide the user with relief from dry nasal tissues caused by sickness or arid environmental conditions. The gel can …
USPTO Abstract
A hydrating nasal gel for shooting nasal tissues within the nasal cavity is described. The gel remains inside the nasal cavity for a substantial period of time to provide the user with relief from dry nasal tissues caused by sickness or arid environmental conditions. The gel can be applied using an applicator tip that applies the gel to the nasal tissues within the nasal cavity, substantially without applying the gel within the nasal passage.
Drugs covered by this patent
- Androgel (TESTOSTERONE) · Besins Hlthcare
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.